Dizal’s lung cancer pill approval sets up competition with J&Jnews2025-07-03T10:42:42+00:00July 3rd, 2025|Endpoints News|
How FDA staff defied Prasad’s vaccine framework in Moderna reviewnews2025-07-02T19:08:04+00:00July 2nd, 2025|Endpoints News|
AbbVie loses bid to block Tennessee’s 340B contract pharmacy lawnews2025-07-02T17:03:11+00:00July 2nd, 2025|Endpoints News|
CDC expands RSV vaccine recommendations, siding with previous panel of agency advisorsnews2025-07-02T16:08:20+00:00July 2nd, 2025|Endpoints News|
After delay, Regeneron wins US approval of bispecific in multiple myelomanews2025-07-02T15:40:44+00:00July 2nd, 2025|Endpoints News|
AbbVie cans oral ulcerative colitis drug from Landos buyoutnews2025-07-02T15:28:28+00:00July 2nd, 2025|Endpoints News|
Soriot mulls moving AstraZeneca stock listing to the US — reportnews2025-07-02T11:20:43+00:00July 2nd, 2025|Endpoints News|
Federal judge orders block on parts of HHS reorganization plan after states suenews2025-07-01T20:24:17+00:00July 1st, 2025|Endpoints News|
PBM reforms fail to make Senate version of Trump’s megabillnews2025-07-01T20:00:46+00:00July 1st, 2025|Endpoints News|
Supreme Court passes on Oklahoma’s drug middlemen spatnews2025-06-30T20:01:25+00:00June 30th, 2025|Endpoints News|
